Ryan Barbara
MiNK Therapeutics, Inc. · Director
Ryan Barbara is listed in filings as Director at MiNK Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity and purchase activity. Recent filings connect the profile to MiNK Therapeutics, Inc. (INKT), Indivior Pharmaceuticals Inc (INDV), and Azitra, Inc. (AZTR). The current snapshot covers public activity from Sep 5, 2024 to Jun 5, 2026. Reported amounts are shown as $12.8K to $17.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $2498 shares | BuyMar 13, 2026 | $31.09 | $40.54 | |
| $4.6k300 shares | SellMar 10, 2026 | $15.28 | $10.66 | |
| $7.8k500 shares | SellMar 10, 2026 | $15.57 | $10.66 | |
| $7.7k500 shares | SellMar 10, 2026 | $15.30 | $10.66 | |
| $2k200 shares | SellMar 9, 2026 | $10.17 | $10.66 | |
| $1k31 shares | BuyMar 9, 2026 | $32.56 | $40.54 | |
| $1.1k100 shares | SellMar 2, 2026 | $10.83 | $10.66 | |
| $4.3k400 shares | SellFeb 27, 2026 | $10.86 | $10.66 | |
| $27k775 shares | BuyJan 5, 2026 | $35.39 | $40.54 |